gp100

This is a HLA-A*0201 restricted epitope used in melanoma studies.

Gp100 (25-33) corresponds to residues 25 to 33 of the mouse self/tumor antigen glycoprotein (mgp100), which is an enzyme responsible for pigment synthesis. This epitope fragment is found in both normal melanocytes and melanoma cells.

Gp100 (25-33), human TFA is a 25-33 amino acid fragment of human melanoma antigen.Gp100 (25-33), human TFA is a 9-amino acid (AA) epitopes restricted by h-2db and recognized by T cells.

Gp100 (25-33), human is the amino acids 25-33 fragment of the human melanoma antigen. It is a 9-amino acid (AA) epitope restricted by H-2Db and recognized by the T cells.This is amino acids 25 to 33 fragment of human melanoma antigen gp100. This H-2Db res

Tebentafusp (IMCgp100) is a protein that specifically targets gp100 and consists of a soluble T-cell receptor functionally fused to an anti-CD3 immune effector Tebentafusp has potential anti-tumor activity, induces the production of inflammatory cytokines and cytolytic proteins, and can be used to study unresectable or metastatic uveal melanoma.

Gp100 (619-627) acetate refers to the amino acid fragment 619 to 627 of the human melanoma antigen glycoprotein 100 (gp100). This compound has been extensively studied as a target in melanoma immunotherapy research.

Gp100 (25-33), mouse TFA is a sequence located at residues 25-33 of the mouse self/tumor antigen glycoprotein (Mgp100). This enzyme participates in pigment synthesis, and its epitope fragment is expressed in both normal melanocytes and melanoma cells.

gp100 (17-25) is an immunogenic polypeptide capable of inducing tumor-specific, HLA-A3-restricted T lymphocytes and is employed in melanoma research.

Gp100:209-217, a gp 100-derived human CTL epitope presented by HLA-A2, is an eight-amino-acid polypeptide that acts as a potent TGF-β inhibitor, blocking the TGF-β signaling pathway [1].

Anti-PMEL Antibody is a potent monoclonal antibody targeting the melanocyte-specific protein PMEL (gp100), acting by specifically binding to the fibrillar matrix formed during melanosome maturation. The compound is an essential tool for investigating melanocyte differentiation, melanosome biogenesis, and pigmentation-related pathological mechanisms, aiming to quantitatively evaluate cellular metabolic and differentiation states by identifying processed, mature PMEL proteins.

The G280-9 peptide, a common melanoma gp100 epitope restricted by MHC-associated HLA-A2. The G280-9 sequence is unique because it could be recognized by cytotoxic T lymphocytes at very low concentrations, however it shows low total immunogenicity that may

G280-9 acetate is a common melanoma gp100 epitope restricted by MHC-associated HLA-A2. The G280-9 sequence is unique because it could be recognized by cytotoxic T lymphocytes at very low concentrations, however it shows low total immunogenicity that may b

G209-2M is an eight-amino-acid peptide derived from the melanoma self-antigen gp100, resulting in a significant increase in circulating CTLs with highly specific activity directed against a tumor antigen target [1].